QT
BBIO icon

Quantbot Technologies’s BridgeBio Pharma BBIO Stock Holding History

Quantbot Technologies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,410
Closed -$56.9K – 1559
2023
Q4 		$56.9K Buy
+1,410
New +$42.3K ﹤0.01% 1312
2023
Q2 		– Sell
-2,800
Closed -$46.4K – 1576
2023
Q1 		$46.4K Buy
+2,800
New +$32.6K ﹤0.01% 1262
2022
Q4 		– Sell
-32,995
Closed -$327K – 1677
2022
Q3 		$327K Buy
32,995
+31,028
+1,577% +$322K 0.02% 723
2022
Q2 		$17K Sell
1,967
-2,233
-53% -$18.7K ﹤0.01% 1462
2022
Q1 		$42K Buy
4,200
+3,500
+500% +$35.9K ﹤0.01% 1234
2021
Q4 		$11K Sell
700
-10,858
-94% -$459K ﹤0.01% 1302
2021
Q3 		$541K Buy
11,558
+9,258
+403% +$496K 0.04% 575
2021
Q2 		$140K Buy
+2,300
New +$131K 0.01% 837
2021
Q1 		– Sell
-1,100
Closed -$78K – 1412
2020
Q4 		$78K Buy
1,100
+700
+175% +$33.8K 0.01% 790
2020
Q3 		$15K Buy
+400
New +$12.6K ﹤0.01% 1045

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantbot Technologies's BBIO Position: Q1 2024 in Review

Quantbot Technologies sold out of BridgeBio Pharma (BBIO) in Q1 2024, closing a stake of 1,410 shares — an estimated $56.9K sold.

Quantbot Technologies first reported a position in BBIO in Q3 2020 and held it in 10 quarters. The position peaked at $541K in Q3 2021. 244 funds tracked by Wall St. Rank hold BBIO as of Q1 2024.

  • Quantbot Technologies reported no remaining BridgeBio Pharma position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,410 BridgeBio Pharma shares in Q1 2024, an estimated $56.9K.
  • Quantbot Technologies first reported a position in BridgeBio Pharma in Q3 2020 and held it in 10 quarters.
  • Quantbot Technologies's BridgeBio Pharma position peaked at $541K in Q3 2021.
  • 244 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.